Hydrazides as Inhibitors of Histone Deacetylases

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Pharmacology

Background:

• Histone deacetylase inhibitors (HDACis) are crucial therapeutic agents.
• Traditional HDACis utilize hydroxamic acid or o-aminoanilide zinc-binding groups (ZBGs).
• A need exists for novel ZBG-bearing HDACis with improved selectivity and efficacy.

Purpose of the Study:

• To review the biological evidence for hydrazides as a distinct class of ZBG-bearing HDACis.
• To highlight the potential of N-alkyl hydrazides as innovative chemical tools for HDAC inhibition.
• To explore the therapeutic applications of hydrazide-based HDACis.

Main Methods:

• Comprehensive literature review of existing biological data on hydrazides as HDACis.
• Analysis of the chemical properties and ZBG characteristics of hydrazides.
• Comparison of hydrazide-based HDACis with traditional ZBG-bearing HDACis.

Main Results:

• Hydrazides represent a novel and distinct class of ZBG-bearing HDACis.
• N-alkyl hydrazides demonstrate selective and effective inhibition of specific HDAC enzymes.
• This class of inhibitors offers a new avenue for drug development.

Conclusions:

• Hydrazides are a promising new class of HDAC inhibitors with unique ZBG properties.
• N-alkyl hydrazides provide innovative chemical tools for targeted therapy.
• These inhibitors hold potential for treating neurodegenerative diseases, cancer, cardiovascular diseases, and protozoal infections.